- The UK’s drug regulator on Monday said it had approved an updated Moderna vaccine which is supposed to offer better protection against the so-called “Omicron” variant of COVID-19.
- As in late 2020, when the UK rushed to become the first country to approve the first COVID vaccine, the MHRA decision came ahead of pending ones expected soon from European regulators, among others.
- Moderna calls the new vaccine “bivalent” because it is designed to stimulate an immune response against two different antigens — both the original COVID variant and the first “Omicron” (or BA.1) variant.
UK approves Omicron-ready COVID vaccine 15.08.2022
